NIH Archive
-
December 8, 2023
You missed a few: a better way to count health care-associated influenza cases
The traditional definition of health care-associated influenza leads to gross undercounting, a Vanderbilt study suggests. -
December 5, 2023
Role of immunity in kidney injury hints at a potential therapy: study
Targeting the cytokine IL-22 could be a new therapeutic approach to prevent kidney injury caused by drugs or toxins, Vanderbilt researchers have discovered. -
December 4, 2023
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. -
November 21, 2023
Commensal gut bacterium protects from severe intestinal infection
The commensal bacterium Turicibacter sanguinis could be used to protect against severe intestinal infections, Vanderbilt researchers discovered. -
November 16, 2023
Nasty microbe H. pylori has Achilles’ heel
Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection. -
November 15, 2023
Study finds many patients don’t seek more health services after receiving genetic screening results
A study by Vanderbilt researchers found that more than half of the patients who receive the results of genetic tests might not be impelled to seek more services than they're already receiving. -
November 15, 2023
Novel C. diff structures are required for infection, offer new therapeutic targets
Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs.